Mycophenolic Acid
Back to searchMolecule Structure
Scientific Name
Mycophenolic Acid
Description of the Drug
Mycophenolic acid is an immunosuppressant used to prevent organ transplant rejections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01024
http://www.drugbank.ca/drugs/DB01024
Brand Name(s)
Mycophenolic acid, Myfortic
Company Owner(s)
Apotex Inc, Alkem Laboratories Ltd, Novartis Pharmaceuticals Corp, Twi Pharmaceuticals Inc, Amta Labs Ltd, Accord Healthcare Inc, Biocon Pharma Ltd, Teva Pharmaceuticals Usa, Rk Pharma Inc, Concord Biotech Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Inosine-5′-monophosphate dehydrogenase (IMPDH) | PROTEIN FAMILY | INHIBITOR | CHEMBL2111369 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4549 | |||
| PharmGKB | PA164748728 | |||
| Human Metabolome Database | HMDB0015159 | |||
| DrugBank | DB01024 | |||
| PubChem: Thomson Pharma | 14850485 | |||
| PubChem | 446541 | |||
| Mcule | MCULE-1991681277 | |||
| NMRShiftDB | 70011881 | |||
| LINCS | LSM-42933 | |||
| Nikkaji | J49.437B | J2.768E | ||
| PDBe | MOA | |||
| BindingDB | 19264 | |||
| EPA CompTox Dashboard | DTXSID4041070 | |||
| DrugCentral | 1860 | |||
| Metabolights | MTBLC168396 | |||
| Brenda | 216043 | 570 | 6557 | |
| ChemicalBook | CB8311003 | CB4507365 | ||
| Guide to Pharmacology | 6832 | |||
| rxnorm | MYFORTIC | MYCOPHENOLATE SODIUM | MYCOPHENOLATE | MYCOPHENOLIC ACID |
| ChEBI | 168396 | |||
| ZINC | ZINC000000001758 |
